Dear ProHealth Community, Many of you stocked up on NMN in anticipation of the FDA's expected July 31st decision. As of now, that decision has been delayed. Due to staffing cuts in key regulatory divisions, the FDA has postponed its response and now expects to issue an update by September 30, 2025. So what does this mean? For the time being, NMN remains fully available. And while the outcome is still uncertain, we remain optimistic that both the science—and your continued support—will help shape a positive path forward. We'll keep you updated as we learn more. In health, Dr. Nick Bitz Chief Science Officer, ProHealth Longevity |